General Gynecology
O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee.
20 Jan, 2022 | 08:59h | UTC
Review: Diagnosis and treatment of polycystic ovary syndrome.
20 Jan, 2022 | 08:54h | UTCDiagnosis and Treatment of Polycystic Ovary Syndrome – JAMA (free for a limited period)
Cohort Study: Factors associated with 10-year declines in physical health and function among women during midlife.
19 Jan, 2022 | 08:29h | UTCCommentary: Four Factors in Midlife Predict a Healthy Old Age for Women – HealthDay
Association of hormonal contraceptive use with adverse health outcomes: an umbrella review of meta-analyses of randomized clinical trials and cohort studies.
18 Jan, 2022 | 09:29h | UTC
M-A: Combined oral contraceptives may improve overall premenstrual symptomatology but are not helpful for premenstrual depressive symptoms.
14 Jan, 2022 | 07:49h | UTCCommentary: ‘Optimal’ treatment for premenstrual depressive symptoms remains elusive – Healio (free registration required)
Risk of reoperation 10 years after surgical treatment for stress urinary incontinence: a national population-based cohort study.
14 Jan, 2022 | 07:51h | UTC
Commentary on Twitter
Risk of reoperation 10 years after surgical treatment for stress urinary incontinence: a national population-based cohort study https://t.co/Z4oCv1XHC8 pic.twitter.com/DTsvd9EyIF
— AJOG (@AJOG_thegray) December 27, 2021
Review: Diagnosis and treatment of sexually transmitted infections.
13 Jan, 2022 | 08:38h | UTCDiagnosis and Treatment of Sexually Transmitted Infections: A Review – JAMA (free for a limited period)
Systematic Review: The effectiveness and safety of treatments for recurrent vulvovaginal candidiasis.
11 Jan, 2022 | 02:24h | UTCTreatment for recurrent vulvovaginal candidiasis (thrush) – Cochrane Library
FDA approves first injectable treatment for HIV pre-exposure prevention.
8 Jan, 2022 | 23:04h | UTCCommentaries:
NIH celebrates FDA approval of long-acting injectable drug for HIV prevention – NIH News Releases
A new injection to prevent HIV, rather than pills, is a game-changer, scientists say – NPR
Related:
CDC Guidance: Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents
USPSTF Statement: Preexposure Prophylaxis for the Prevention of HIV Infection
British Guidelines on the Use of HIV Pre–exposure Prophylaxis (PrEP) (several guidelines on the subject)
New Protocol for HIV Prevention Drug Reduces The Number Of Pills Required
Abortion safety and use with normally prescribed Mifepristone in Canada.
16 Dec, 2021 | 08:51h | UTCNews Release: Prescribing the abortion pill without restrictions is safe and effective, study finds – University of British Columbia
Short Review: Lymphogranuloma venereum.
14 Dec, 2021 | 08:42h | UTCLymphogranuloma venereum – Canadian Medical Association Journal
NICE Guideline | Pelvic floor dysfunction: prevention and non-surgical management.
13 Dec, 2021 | 09:43h | UTC
Review: Endometrial cancer.
13 Dec, 2021 | 08:43h | UTCEndometrial cancer – Nature Reviews Disease Primers (free for a limited period – if the link is paywalled, try this one)
Infographic: Endometrial cancer (free for a limited period – if the link is paywalled, try this one)
Cohort Study: Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality.
13 Dec, 2021 | 08:42h | UTC
Commentary on Twitter
This observational study found that bilateral salpingo-oophorectomy at non-malignant hysterectomy appeared to be associated with increased all cause mortality in women aged <50 years, but not in those aged ≥50 years https://t.co/I0b9nrht9V
— The BMJ (@bmj_latest) December 11, 2021
Evaluation and management of pelvic organ prolapse.
8 Dec, 2021 | 09:50h | UTCEvaluation and Management of Pelvic Organ Prolapse – Mayo Clinic Proceedings
RCT: Cytoreductive surgery for relapsed ovarian cancer.
2 Dec, 2021 | 09:51h | UTC
[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.
21 Nov, 2021 | 22:56h | UTCRelated:
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination
Meta-Analysis: Population-level Impact of HPV Vaccination Programs
Recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic.
19 Nov, 2021 | 10:33h | UTC
Large observational study suggests prolactin-increasing antipsychotics are associated with increased risk of breast cancer (OR=1.56 for over 5 years of exposure); prolactin-sparing antipsychotics (including clozapine, quetiapine, or aripiprazole), on the other hand, were not associated with increased risk.
10 Nov, 2021 | 06:57h | UTCAntipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
Nested case-control study: ≥5 years exposure to prolactin-sparing APDs was not associated with an increased risk of breast cancer vs.<1 year exposure (aOR=1.19; 0.90–1.58). The opposite was observed with APDs that increase prolactin (aOR=1.56; 1.27–1.92) https://t.co/LwCVyTH051
— P𝘧OL (@psychopharmacol) September 12, 2021
A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.
4 Nov, 2021 | 09:58h | UTCRelated:
CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination
Meta-Analysis: Population-level Impact of HPV Vaccination Programs
Commentary on Twitter
NEW—Cervical cancer rates 87% lower in women offered vaccination against human papillomavirus (#HPV) between ages 12-13 than in previous generations, English study confirms.
First direct evidence of cervical cancer prevention using bivalent vaccine: https://t.co/HdQbGIKxZp pic.twitter.com/PMFermHGOv
— The Lancet (@TheLancet) November 3, 2021
Cohort Study: Hypertensive disorders of pregnancy are associated with a 6-fold or higher increased risk of chronic hypertension in the first years following delivery.
21 Oct, 2021 | 09:51h | UTCEditorial: Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION
Commentary on Twitter
Hypertensive disorders of pregnancy and onset of chronic hypertension in France: the nationwide CONCEPTION study@escardio #EHJ #cardiotwitterhttps://t.co/OnJRP94W6v pic.twitter.com/N3dLNTD5XU
— EHJ Editor-in-Chief (@ehj_ed) October 17, 2021
RCT: Laser treatment not better than sham treatment on symptom severity in women with postmenopausal vaginal symptoms.
13 Oct, 2021 | 01:30h | UTCEffect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Time for a “Pause” on the Use of Vaginal Laser (free for a limited period)
Author Interview: Effect of Carbon Dioxide Laser vs Sham Therapy on Women With Postmenopausal Vaginal Symptoms
Commentary: Vagina lasering for postmenopausal women ‘may be placebo’ – The Guardian
Commentary on Twitter
In a randomized clinical trial among women with postmenopausal vaginal symptoms, treatment with fractional carbon dioxide laser vs sham treatment did not improve vaginal symptoms after 12 months https://t.co/XXv5edTLiL
— JAMA (@JAMA_current) October 12, 2021
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018.
13 Oct, 2021 | 01:21h | UTCInvited commentary: Anemia in women — an intractable problem that requires innovative solutions – Nature Medicine
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18 – In many countries, ciprofloxacin resistance was exceedingly high, and decreased susceptibility or resistance to ceftriaxone and cefixime continued to emerge.
24 Sep, 2021 | 08:53h | UTC
RCT: Tamsulosin may prevent postoperative urinary retention following female pelvic reconstructive surgery.
17 Sep, 2021 | 09:56h | UTCTamsulosin vs placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery: a multicenter randomized controlled trial – American Journal of Obstetrics & Gynecology (link to abstract – $ for full-text)